Our CEO is responsible for the strategic decisions related to Tillotts. He sets the company objectives based on the input from the Senior Management Committee (SMC-O), in line with our vision and mission. Learn more about each member here.
Thomas A. Tóth von Kiskér,
Chief Executive Officer
Thomas A. Tóth von Kiskér has been with Tillotts for more than 25 years in various roles and positions.
Since January 2008, he has been the CEO of Tillotts.
The Senior Management Committee – Operational, responsible for the operational activities at Tillotts, consists of nine experienced managers, with Thomas A. Tóth von Kiskér serving as the chair of the committee.
Moreover, they monitor the activities of the organisation to ensure they are in line with our company objectives and values.
Oliver Isch
Head of Finance
Oliver Isch joined Tillotts in 2016 as Senior Business Controller. In September 2024, he was promoted to Head of Finance. Prior to working for Tillotts, he worked in various industries as Controller and Risk Manager. He is a Chartered Expert in Financial and Managerial Accounting and Reporting and has 20 years of experience in this field.
Gabriella Schraner
Head of HR
Gabriella Schraner joined Tillotts in 2013. In February 2016, she was promoted to Head of HR. She is a Human Resources expert by training with specialization in International HR with more than 10 years of experience. Prior to Tillotts, she mainly worked in the biotechnology industry.
Harald Haubitz
Head of Technical Operations
Harald Haubitz joined Tillotts in January 2018. He is a pharmacist by training with over 25 years of experience in the pharmaceutical industry. Previously he held different management positions at Roche and was the COO of Acino for several years before he ran his own consultancy business.
Adrian Hill
Head of Commercial Operations
Adrian Hill joined Tillotts in January 2019. He has more than 25 years experience in commercial activities including experience in global marketing from several companies including Sanofi, GSK and most recently Kyowa Kirin.
Johannes Spleiss
Head of Scientific Affairs
Johannes Spleiss joined Tillotts in November 1998. He took on positions of increasing responsibility and is now leading R&D, Medical Affairs, Drug Safety and Regulatory Affairs. A chemist by training, he has 30 years of experience in the pharmaceutical industry.
Mirjam von Zedtwitz
General Counsel
Mirjam von Zedtwitz joined Tillotts in July 2024. She is a German qualified attorney with more than 20 years of experience working as in-house counsel in the pharmaceutical, biotechnology and medical technology industry.
Ragip Ziyal
Head of Business Development & Licensing International
Ragip Ziyal joined Tillotts in April 2014. He has 25 years of experience in global Business, Corporate Development and Licensing functions working for Merz Pharmaceuticals, Fujisawa (now Astellas), Altana/Nycomed/Takeda. He is a licensed pharmacist by training, has a PhD degree in pharmacology in Germany and holds an MBA from Warwick Business School, UK.
Jeremy Thorpe
Managing Director of Tillotts Pharma UK
Jeremy joined Tillotts in July 2012 to establish the UK affiliate bringing with him over 25 years of experience in pharmaceuticals and healthcare working in a variety of commercially focused roles in well-known and smaller / start-up companies. Jeremy has a strong entrepreneurial spirit and has a background in business and economics.